As of Jan 20
| +0.0194 / +3.47%|
The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The median estimate represents a +202.30% increase from the last price of 0.58.
The current consensus among 1 polled investment analysts is to Buy stock in Pain Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.